Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Regen BioPharma, Inc.
No Price
Closing Price OTC 01.05.2026:
0,005 USD
01.05.2026 19:09
Current Prices from Regen BioPharma, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
RGBPP
USD
01.05.2026 19:09
0,005 USD
0,001 USD
+28,57 %
Company Profile for Regen BioPharma, Inc. Share
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
